In the early 1960s, after studies confirmed that it was linked to congenital disorders in more than 10,000 children, ...

It’s not known whether Rystiggo (rozanolixizumab) is safe to receive while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy may determine ...

In 2016, EULAR - The European Alliance of Associations for Rheumatology - published points-to-consider on the use of antirheumatic drugs in reproduction, pregnancy, and lactation. Since then, new ...

Voranigo (vorasidenib) is not safe to take while pregnant or breastfeeding. Certain factors, including the risk fetal harm, may determine whether you should take the drug during this time. Voranigo is ...

MINNEAPOLIS — Despite evidence of the risk of malformations at birth, or birth defects, use of some antiseizure drugs during pregnancy has persisted, according to a study published on July 23, 2025, ...

New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated risks for preterm birth and pregnancy-related complications, raising urgent ...

Hospitals routinely use unreliable drug tests at childbirth, and many parents are reported to child welfare agencies and the police. Here’s what you can do.

Women who stop taking GLP-1 medications just prior to a pregnancy appear to be at higher odds for weight gain and complications, researchers said. File Photo by Terry Schmitt/UPI Women who stop taking ...

Almut Winterstein consults on medication safety issues to Merck, Syneos, Lykos and Novo Nordisk. She receives funding for pregnancy-related research from NIH, CDC, FDA, and the Gates Foundation. Sonja ...

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular GLP-1 weight loss medications either before or early in their pregnancy were found to gain more ...